Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 76420-945

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 76420-945). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

A line graph comparing the cumulative incidence percentage over years for Atorvastatin versus Placebo. The solid line represents Atorvastatin with a lower cumulative incidence, and the dashed line represents Placebo with a higher cumulative incidence. The x-axis shows time in years up to 3.5 years, and the y-axis shows cumulative incidence percentage up to 4.0%. Hazard ratio and p-value are indicated below the graph.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

A line graph comparing cumulative hazard percentages over time between Atorvastatin and placebo groups. The x-axis shows years of follow-up up to 5 years, and the y-axis shows cumulative hazard percentage up to 15%. The graph includes a hazard ratio (HR) of 0.63 with confidence interval 0.48-0.83 and p-value 0.001, indicating data from a clinical study involving Atorvastatin Calcium tablets.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

A line graph showing the percentage of subjects experiencing an event over time in years to the first major cardiovascular endpoint. It compares two Atorvastatin doses: 10 mg (dashed line) and 80 mg (solid line), indicating lower event percentages with the 80 mg dose.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Chemical structure of Atorvastatin Calcium showing its molecular arrangement, including aromatic rings, hydroxyl groups, and calcium with associated water molecules (Ca2+ and 3H2O). This illustration represents the active ingredient Atorvastatin Calcium used in oral film-coated tablets.*

FDA Label Image

10 (Label 10mg)

Labels for Atorvastatin Calcium Tablets USP 10 mg by Enovachem Pharmaceuticals, manufactured and distributed by Ascend Laboratories, LLC. The labels show various package quantities including 20, 30, 60, 90, 100, 120, 500, 1000, and 5000 tablets. Each label includes the NDC codes, storage instructions, and a caution statement regarding prescription dispensing, along with barcodes and QR codes.*

FDA Label Image

20 (Label 20mg)

Multiple labels for Atorvastatin Calcium Tablets USP 20 mg film-coated tablets by Enovachem Pharmaceuticals. Labels show various package sizes including quantities 20, 30, 60, 90, 100, 120, 500, 1000, and 4000 tablets. Distributed by Ascend Laboratories, LLC, each label includes NDC numbers, lot and batch numbers, storage instructions, and federal dispensing warnings.*

FDA Label Image

40 (Label 40mg)

Labels for Atorvastatin Calcium Tablets, USP 40 mg by Enovachem Pharmaceuticals relabeled from Ascend Laboratories, LLC. The labels show various package sizes including 90, 500, 1000, 2000, 100, 20, 30, 60, and 120 tablets. Each label includes NDC numbers, batch, lot, expiration placeholders, and storage instructions. The tablets are described as white/oval-shaped film coated with debossed 40;ATS.*

FDA Label Image

80 (Label 80mg)

The image shows multiple label designs for Atorvastatin Calcium Tablets, USP 80 mg by Enovachem Pharmaceuticals. Labels include details such as NDC numbers and quantities ranging from 20 to 100 tablets. The labels indicate the product is film-coated tablets, white and oval-shaped, distributed by Ascend Laboratories, LLC. Storage instructions and prescription-only status are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.